GSK Wins Court Ruling in Pfizer-BioNTech Covid Vaccine Patent Fight
A U.S. judge dismissed Acuitas Therapeutics’ attempt to clear Pfizer and BioNTech’s Comirnaty vaccine of GSK patent claims, citing lack of jurisdiction, Bloomberg Law reported Friday. The decision keeps the focus on GSK’s main Delaware lawsuit alleging Comirnaty infringes mRNA-vaccine patents. Pfizer has pledged to defend its position. The ruling does not address whether infringement occurred.
